Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer

International Journal of Cancer

Volumn 128, Issue 6, 2011, Pages 1327-1334

  Wiklund, Erik D ^a,b   Bramsen, Jesper B ^a   Hulf, Toby ^b   Dyrskjøt, Lars ^c   Ramanathan, Ramshanker ^c   Hansen, Thomas B ^a   Villadsen, Sune B ^a   Gao, Shan ^a   Ostenfeld, Marie S ^c   Borre, Michael ^c   Peter, Marcus E ^d   Ørntoft, Torben F ^c   Kjems, Jørgen ^a   Clark, Susan J ^b  

^a AARHUS UNIVERSITY   (Denmark)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

bladder cancer; DNA methylation; epigenetics; miR 200 family; miR 205; tumor invasion; TWIST1

Indexed keywords

MICRORNA; MICRORNA 200; MICRORNA 205; TRANSCRIPTION FACTOR TWIST; TRANSCRIPTION FACTOR TWIST1; UNCLASSIFIED DRUG;

ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CANCER STAGING; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCUS; GENE SILENCING; GENETIC CORRELATION; HUMAN; HUMAN CELL; MASS SPECTROMETRY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; TRANSCRIPTION REGULATION;

CELLS, CULTURED; DNA METHYLATION; EPIGENOMICS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; POLYMERASE CHAIN REACTION; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 79551469293     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25461     Document Type: Article

References (29)

1. Bartel DP,. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-97.
2. Esquela-Kerscher A, Slack FJ,. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259-69.
3. Gottardo F, Liu CG, Ferracin M, Calin GA, Fassan M, Bassi P, Sevignani C, Byrne D, Negrini M, Pagano F, Gomella LG, Croce CM, et al. Micro-RNA profiling in kidney and bladder cancers. Urol Oncol 2007; 25: 387-92.
4. Dyrskjot L, Ostenfeld MS, Bramsen JB, Silahtaroglu AN, Lamy P, Ramanathan R, Fristrup N, Jensen JL, Andersen CL, Zieger K, Kauppinen S, Ulhoi BP, et al. Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro. Cancer Res 2009; 69: 4851-60.
5. Park SM, Gaur AB, Lengyel E, Peter ME,. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 2008; 22: 894-907.
6. Korpal M, Lee ES, Hu G, Kang Y,. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem 2008; 283: 14910-4.
7. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ,. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008; 10: 593-601.
8. Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, Spaderna S, Brabletz T,. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep 2008; 9: 582-9.
9. Bracken CP, Gregory PA, Kolesnikoff N, Bert AG, Wang J, Shannon MF, Goodall GJ,. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res 2008; 68: 7846-54.
10. Wellner U, Schubert J, Burk UC, Schmalhofer O, Zhu F, Sonntag A, Waldvogel B, Vannier C, Darling D, zur Hausen A, Brunton VG, Morton J, et al. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol 2009; 11: 1487-95.
11. Shimono Y, Zabala M, Cho RW, Lobo N, Dalerba P, Qian D, Diehn M, Liu H, Panula SP, Chiao E, Dirbas FM, Somlo G, et al. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 2009; 138: 592-603.
12. Sharma S, Kelly TK, Jones PA,. Epigenetics in cancer. Carcinogenesis 31: 27-36.
13. Lujambio A, Ropero S, Ballestar E, Fraga MF, Cerrato C, Setien F, Casado S, Suarez-Gauthier A, Sanchez-Cespedes M, Git A, Spiteri I, Das PP, et al. Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res 2007; 67: 1424-9.
14. Weber B, Stresemann C, Brueckner B, Lyko F,. Methylation of human microRNA genes in normal and neoplastic cells. Cell Cycle 2007; 6: 1001-5.
15. Dyrskjot L, Zieger K, Kruhoffer M, Thykjaer T, Jensen JL, Primdahl H, Aziz N, Marcussen N, Moller K, Orntoft TF,. A molecular signature in superficial bladder carcinoma predicts clinical outcome. Clin Cancer Res 2005; 11: 4029-36.
16. Schepeler T, Reinert JT, Ostenfeld MS, Christensen LL, Silahtaroglu AN, Dyrskjot L, Wiuf C, Sorensen FJ, Kruhoffer M, Laurberg S, Kauppinen S, Orntoft TF, et al. Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res 2008; 68: 6416-24.
17. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP,. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998; 4: 844-7.
18. Rice P, Longden I, Bleasby A,. EMBOSS: the European Molecular Biology Open Software Suite. Trends Genet 2000; 16: 276-7.
19. Clark SJ, Statham A, Stirzaker C, Molloy PL, Frommer M,. DNA methylation: bisulphite modification and analysis. Nat Protoc 2006; 1: 2353-64.
20. Coolen MW, Statham AL, Gardiner-Garden M, Clark SJ,. Genomic profiling of CpG methylation and allelic specificity using quantitative high-throughput mass spectrometry: critical evaluation and improvements. Nucleic Acids Res 2007; 35: e119.
21. Clark SJ, Harrison J, Paul CL, Frommer M,. High sensitivity mapping of methylated cytosines. Nucleic Acids Res 1994; 22: 2990-7.
22. Hinshelwood RA, Huschtscha LI, Melki J, Stirzaker C, Abdipranoto A, Vissel B, Ravasi T, Wells CA, Hume DA, Reddel RR, Clark SJ,. Concordant epigenetic silencing of transforming growth factor-beta signaling pathway genes occurs early in breast carcinogenesis. Cancer Res 2007; 67: 11517-27.
23. Aaboe M, Marcussen N, Jensen KM, Thykjaer T, Dyrskjot L, Orntoft TF,. Gene expression profiling of noninvasive primary urothelial tumours using microarrays. Br J Cancer 2005; 93: 1182-90.
24. Wu Z, Irizarry RA,. Preprocessing of oligonucleotide array data. Nat Biotechnol 2004; 22: 656-8; author reply 8.
25. Hurteau GJ, Carlson JA, Roos E, Brock GJ,. Stable expression of miR-200c alone is sufficient to regulate TCF8 (ZEB1) and restore E-cadherin expression. Cell Cycle 2009; 8: 2064-9.
26. Quandt K, Frech K, Karas H, Wingender E, Werner T,. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res 1995; 23: 4878-84.
27. Vesuna F, van Diest P, Chen JH, Raman V,. Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer. Biochem Biophys Res Commun 2008; 367: 235-41.
28. Eger A, Aigner K, Sonderegger S, Dampier B, Oehler S, Schreiber M, Berx G, Cano A, Beug H, Foisner R,. DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene 2005; 24: 2375-85.
29. Coolen MW, Stirzaker C, Song JZ, Statham AL, Kassir Z, Moreno CS, Young AN, Varma V, Speed TP, Cowley M, Lacaze P, Kaplan W, et al. Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces transcriptional plasticity. Nat Cell Biol 2010; 12: 235-46.